Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
Year: 2001
Type: article
Source: PubMed
Authors: H Kurokawa, C L Arteaga
Institution: Vanderbilt University
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W1792978156
